Icagen Reaffirms Recommendation to Shareholders to Tender Shares
29 août 2011 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 29, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has sent the following letter to stockholders affirming the Board's recommendation...
Icagen Reiterates Its Recommendation That Stockholders Accept Pfizer's Offer of $6 Per Share
16 août 2011 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has mailed the following letter to stockholders reiterating its recommendation that...
Icagen Reports Second Quarter 2011 Financial Results and Operational Highlights
10 août 2011 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the second quarter ended June 30, 2011....
Pfizer to Acquire Icagen
20 juil. 2011 08h30 HE
|
Icagen, Inc.
NEW YORK and RESEARCH TRIANGLE PARK, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE:PFE) and Icagen, Inc. (Nasdaq:ICGN) today announced that they have entered into a definitive merger...
Icagen Issues Statement in Response to Pfizer SEC Filing
24 juin 2011 17h07 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., June 24, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) issued today the following statement:
In response to the filing of a Schedule 13D today by Pfizer Inc. in...
Icagen and Pfizer Initiate Nav 1.7 Phase I Multiple Ascending Dose Study
20 juin 2011 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., June 20, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders which is being...
Icagen Reports First Quarter 2011 Financial Results And Operational Highlights
04 mai 2011 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., May 4, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2011. For...
Icagen Forms Collaboration With Yale School of Medicine and Pfizer to Investigate Potential Novel Pain Treatments
03 mai 2011 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., May 3, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has entered into a three-party collaboration with the Yale School of Medicine and...
Icagen Announces Promotion of Dr. Douglas Krafte to Chief Scientific Officer
25 avr. 2011 16h51 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 25, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced the promotion of Douglas Krafte, Ph.D. to the newly created position of Chief Scientific...
Icagen to Report First Quarter 2011 Results on May 4, 2011
21 avr. 2011 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 21, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2011 financial results on Wednesday, May 4, 2011 before the...